Vijaya B. Joshi, Ph.D. - Publications

Affiliations: 
2014 Pharmacy University of Iowa, Iowa City, IA 
Area:
Pharmacy, Oncology

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Geary SM, Hu Q, Joshi VB, Bowden NB, Salem AK. Diaminosulfide based polymer microparticles as cancer vaccine delivery systems. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 26359124 DOI: 10.1016/J.Jconrel.2015.09.002  0.638
2015 Makkouk A, Joshi VB, Lemke CD, Wongrakpanich A, Olivier AK, Blackwell SE, Salem AK, Weiner GJ. Three steps to breaking immune tolerance to lymphoma: a microparticle approach. Cancer Immunology Research. 3: 389-98. PMID 25627654 DOI: 10.1158/2326-6066.Cir-14-0173  0.608
2015 Makkouk A, Joshi VB, Wongrakpanich A, Lemke CD, Gross BP, Salem AK, Weiner GJ. Biodegradable microparticles loaded with doxorubicin and CpG ODN for in situ immunization against cancer. The Aaps Journal. 17: 184-93. PMID 25331103 DOI: 10.1208/S12248-014-9676-6  0.608
2014 Joshi VB, Adamcakova-Dodd A, Jing X, Wongrakpanich A, Gibson-Corley KN, Thorne PS, Salem AK. Development of a poly (lactic-co-glycolic acid) particle vaccine to protect against house dust mite induced allergy. The Aaps Journal. 16: 975-85. PMID 24981892 DOI: 10.1208/S12248-014-9624-5  0.604
2014 Joshi VB, Geary SM, Salem AK. Production of antigen-loaded biodegradable nanoparticles and uptake by dendritic cells. Methods in Molecular Biology (Clifton, N.J.). 1139: 453-66. PMID 24619699 DOI: 10.1007/978-1-4939-0345-0_35  0.63
2014 Wongrakpanich A, Adamcakova-Dodd A, Xie W, Joshi VB, Mapuskar KA, Geary SM, Spitz DR, Thorne PS, Salem AK. The absence of CpG in plasmid DNA-chitosan polyplexes enhances transfection efficiencies and reduces inflammatory responses in murine lungs. Molecular Pharmaceutics. 11: 1022-31. PMID 24494979 DOI: 10.1021/Mp400689R  0.543
2014 Joshi VB, Geary SM, Gross BP, Wongrakpanich A, Norian LA, Salem AK. Tumor lysate-loaded biodegradable microparticles as cancer vaccines. Expert Review of Vaccines. 13: 9-15. PMID 24219096 DOI: 10.1586/14760584.2014.851606  0.612
2014 Makkouk A, Joshi VB, Lemke CD, Wongrakpanich A, Olivier AK, Blackwell SE, Salem AK, Weiner GJ. Three Steps to Breaking Immune Tolerance: A Microparticle Approach Blood. 124: 4504-4504. DOI: 10.1182/Blood.V124.21.4504.4504  0.604
2014 Gross BP, Wongrapanich A, Francis M, Joshi VB, Salem AK, Norian LA. Abstract 2885: Therapeutic microparticle-based tumor lysate vaccination reduces spontaneous lung metastases in a murine breast cancer model Cancer Research. 74: 2885-2885. DOI: 10.1158/1538-7445.Am2014-2885  0.574
2014 Santillan D, Hunter S, Salem A, Conklin J, Joshi V, Santillan M. 429: Microparticles surface functionalized with mannose generate strong initial IgG responses against Group B Streptococcus American Journal of Obstetrics and Gynecology. 210: S217. DOI: 10.1016/J.Ajog.2013.10.462  0.49
2013 Worthington KL, Adamcakova-Dodd A, Wongrakpanich A, Mudunkotuwa IA, Mapuskar KA, Joshi VB, Allan Guymon C, Spitz DR, Grassian VH, Thorne PS, Salem AK. Chitosan coating of copper nanoparticles reduces in vitro toxicity and increases inflammation in the lung. Nanotechnology. 24: 395101. PMID 24008224 DOI: 10.1088/0957-4484/24/39/395101  0.519
2013 Joshi VB, Geary SM, Salem AK. Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses. Human Vaccines & Immunotherapeutics. 9: 2584-90. PMID 23978910 DOI: 10.4161/Hv.26136  0.603
2013 Wei N, Yu Y, Joshi V, Schmidt T, Qian F, Salem AK, Stanford C, Hong L. Glucocorticoid receptor antagonist and siRNA prevent senescence of human bone marrow mesenchymal stromal cells in vitro. Cell and Tissue Research. 354: 461-70. PMID 23963647 DOI: 10.1007/S00441-013-1700-0  0.579
2013 Lemke CD, Geary SM, Joshi VB, Salem AK. Antigen-coated poly α-hydroxy acid based microparticles for heterologous prime-boost adenovirus based vaccinations. Biomaterials. 34: 2524-9. PMID 23312902 DOI: 10.1016/J.Biomaterials.2012.12.030  0.599
2013 Joshi VB, Geary SM, Carrillo-Conde BR, Narasimhan B, Salem AK. Characterizing the antitumor response in mice treated with antigen-loaded polyanhydride microparticles. Acta Biomaterialia. 9: 5583-9. PMID 23153760 DOI: 10.1016/J.Actbio.2012.11.001  0.624
2013 Joshi VB, Geary SM, Salem AK. Biodegradable particles as vaccine delivery systems: size matters. The Aaps Journal. 15: 85-94. PMID 23054976 DOI: 10.1208/S12248-012-9418-6  0.618
2013 Wongrakpanich A, Joshi VB, Salem AK. Poly(galactaramidoamine) is an efficient cationic polymeric non-viral vector with low cytotoxicity for transfecting human embryonic kidney (HEK293) and murine macrophage (RAW264.7) cells. Pharmaceutical Development and Technology. 18: 1255-8. PMID 22235917 DOI: 10.3109/10837450.2011.649856  0.549
2012 Hong L, Wei N, Joshi V, Yu Y, Kim N, Krishnamachari Y, Zhang Q, Salem AK. Effects of glucocorticoid receptor small interfering RNA delivered using poly lactic-co-glycolic acid microparticles on proliferation and differentiation capabilities of human mesenchymal stromal cells. Tissue Engineering. Part A. 18: 775-84. PMID 21988716 DOI: 10.1089/Ten.Tea.2011.0432  0.693
2011 Hong L, Krishnamachari Y, Seabold D, Joshi V, Schneider G, Salem AK. Intracellular release of 17-β estradiol from cationic polyamidoamine dendrimer surface-modified poly (lactic-co-glycolic acid) microparticles improves osteogenic differentiation of human mesenchymal stromal cells. Tissue Engineering. Part C, Methods. 17: 319-25. PMID 20883116 DOI: 10.1089/Ten.Tec.2010.0388  0.697
Show low-probability matches.